Singular Genomics Systems, Inc. (OMIC): Price and Financial Metrics

Singular Genomics Systems, Inc. (OMIC): $0.52

0.01 (+1.12%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

OMIC Price/Volume Stats

Current price $0.52 52-week high $1.32
Prev. close $0.51 52-week low $0.31
Day low $0.48 Volume 110,400
Day high $0.52 Avg. volume 115,028
50-day MA $0.52 Dividend yield N/A
200-day MA $0.53 Market Cap 38.21M

OMIC Stock Price Chart Interactive Chart >

OMIC POWR Grades

  • Sentiment is the dimension where OMIC ranks best; there it ranks ahead of 47.82% of US stocks.
  • OMIC's strongest trending metric is Quality; it's been moving down over the last 46 days.
  • OMIC ranks lowest in Quality; there it ranks in the 6th percentile.

OMIC Stock Summary

  • SINGULAR GENOMICS SYSTEMS INC's stock had its IPO on May 27, 2021, making it an older stock than just 7.03% of US equities in our set.
  • OMIC's price/sales ratio is 13.94; that's higher than the P/S ratio of 92.15% of US stocks.
  • Revenue growth over the past 12 months for SINGULAR GENOMICS SYSTEMS INC comes in at 239.22%, a number that bests 97.77% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to OMIC, based on their financial statements, market capitalization, and price volatility, are LCTX, FCEL, APLS, NWBO, and LGVN.
  • Visit OMIC's SEC page to see the company's official filings. To visit the company's web site, go to singulargenomics.com.

OMIC Valuation Summary

  • OMIC's EV/EBIT ratio is -0.8; this is 105.48% lower than that of the median Healthcare stock.
  • Over the past 32 months, OMIC's price/earnings ratio has gone up 37.1.

Below are key valuation metrics over time for OMIC.

Stock Date P/S P/B P/E EV/EBIT
OMIC 2023-12-29 13.0 0.2 -0.4 -0.8
OMIC 2023-12-28 13.3 0.2 -0.4 -0.8
OMIC 2023-12-27 12.6 0.2 -0.4 -0.8
OMIC 2023-12-26 11.8 0.2 -0.3 -0.8
OMIC 2023-12-22 12.1 0.2 -0.3 -0.8
OMIC 2023-12-21 11.9 0.2 -0.3 -0.8

OMIC Price Target

For more insight on analysts targets of OMIC, see our OMIC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $30.33 Average Broker Recommendation 1.6 (Moderate Buy)

Singular Genomics Systems, Inc. (OMIC) Company Bio


Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. It manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits; and offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. The company was incorporated in 2016 and is headquartered in La Jolla, California.


OMIC Latest News Stream


Event/Time News Detail
Loading, please wait...

OMIC Latest Social Stream


Loading social stream, please wait...

View Full OMIC Social Stream

Latest OMIC News From Around the Web

Below are the latest news stories about SINGULAR GENOMICS SYSTEMS INC that investors may wish to consider to help them evaluate OMIC as an investment opportunity.

Singular Genomics Systems Founder Acquires 4.6% More Stock

Even if it's not a huge purchase, we think it was good to see that Eli Glezer, the Founder of Singular Genomics...

Yahoo | November 21, 2023

Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q3 2023 Earnings Call Transcript

Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q3 2023 Earnings Call Transcript November 14, 2023 Singular Genomics Systems, Inc. beats earnings expectations. Reported EPS is $-0.31, expectations were $-0.38. Operator: Greetings. Welcome to the Singular Genomics Systems, Inc. Third Quarter 2023 Earnings Conference Call. [Operator Instructions]. I will now turn the conference over to your host, Philip […]

Yahoo | November 15, 2023

Q3 2023 Singular Genomics Systems Inc Earnings Call

Q3 2023 Singular Genomics Systems Inc Earnings Call

Yahoo | November 15, 2023

Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial Results

SAN DIEGO, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the third quarter ended September 30, 2023. “We shipped five G4 systems in the third quarter, our highest quarterly total yet, launched Max Read flow cell kits for single cell sequencing, and saw o

Yahoo | November 14, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Pre-market stock movers are worth checking out on Monday as we cover all of the biggest gainers and losers this morning!

William White on InvestorPlace | November 13, 2023

Read More 'OMIC' Stories Here

OMIC Price Returns

1-mo -11.56%
3-mo 13.02%
6-mo 36.48%
1-year -54.78%
3-year N/A
5-year N/A
YTD 13.02%
2023 -77.11%
2022 -82.61%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!